ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 263-268

  Bessho, Yuji ^a   Oguri, Tetsuya ^a   Ozasa, Hiroaki ^a   Uemura, Takehiro ^a   Sakamoto, Hideo ^a   Miyazaki, Mikinori ^a   Maeno, Ken ^a   Sato, Shigeki ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

ABCB1 MDR1; ABCC10 MRP7; Non small cell lung cancer; Resistance; Vinorelbine

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 7; NAVELBINE; PACLITAXEL; PROTEIN ABCC10; PROTEIN MRP7; SMALL INTERFERING RNA; SULFINPYRAZONE; UNCLASSIFIED DRUG; VERAPAMIL; ABCC10 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; BIOSYNTHESIS; DRUG RESISTANCE; GENETICS; LUNG TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VINBLASTINE;

EID: 61449341856     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000217     Document Type: Article

References (22)

1. Zhou XJ and Rahmani R: Preclinical and clinical pharmacology of vinca alkaloids. Drugs 44: 1-16, 1992.
2. Goa KL and Faulds D: Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs Aging 5: 200-234, 1994.
3. Toso C and Lindley C: Vinorelbine: a novel vinca alkaloid. Am J Health Syst Pharm 52: 1287-1304, 1995.
4. Kajita J, Kuwabara T, Kobayashi H and Kobayashi S: CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes. Drug Metab Dispos 28: 1121-1127, 2000.
5. Sève P, Mackey J, Isaac S, et al: Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther 4: 2001-2007, 2005.
6. Stuckler D, Singhal J, Singhal SS, Yadav S, Awasthi YC and Awasthi S: RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. Cancer Res 65: 991-998, 2005.
7. Dumontet C and Sikic BI: Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol 17: 1061-1070, 1999.
8. Adams DJ and Knick VC: P-glycoprotein mediated resistance to 5′-nor-anhydro-vinblastine (Navelbine). Invest New Drugs 13: 13-21, 1995.
9. Kruh GD and Belinsky MG: The MRP family of drug efflux pumps. Oncogene 22: 7537-7552, 2003.
10. Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG and Kruh GD: Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res 64: 4927-4930, 2004.
11. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer. A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311: 899-909, 1995.
12. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98, 2002.
13. Hirata S, Katoh O, Oguri T, Watanabe H and Yajin K: Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa. Jpn J Cancer Res 91: 84-90, 2000.
14. Oguri T, Isobe T, Fujitaka K, Ishikawa N and Kohno N: Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer. Int J Cancer 93: 584-589, 2001.
15. Etiévant C, Pauwels O and Kiss R: Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines. J Cancer Res Clin Oncol 120: 76-84, 1993.
16. Chen ZS, Hopper-Borge E, Belinsky MG, Shchaveleva I, Kotova E and Kruh GD: Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol 63: 351-358, 2003.
17. Oguri T, Ozasa H, Uemura T, et al: MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small-cell lung cancer. Mol Cancer Ther 7: 1150-1155, 2008.
18. Naramoto H, Uematsu T, Uchihashi T, et al: Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. Int J Oncol 30: 393-401, 2007.
19. Dabrowska M and Sirotnak FM: Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5′ end heterogeneity. Gene 341: 129-139, 2004.
20. Takayanagi S, Kataoka T, Ohara O, Oishi M, Kuo MT and Ishikawa T: Human ATP-binding cassette transporter ABCC10: expression profile and p53-dependent upregulation. J Exp Ther Oncol 4: 239-246, 2004.
21. Stavrovskaya AA: Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry 65: 95-106, 2000.
22. Lai SL, Goldstein LJ, Gottesman MM, et al: MDR1 gene expression in lung cancer. J Natl Cancer Inst 81: 1144-1150, 1989.